In analysis by Edwards et al. [11] a loss of heterozygosity was evident in the five available prostate cancer tumours from group one which indicated a relationship between BRCA2 germline mutations and predisposition to prostate cancer in these individuals. Here, BRCA2 is linked to Familial prostate cancer.